Apotex Health prices upsized initial public offering at $24 per share
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
TORONTO – Drug company Apotex Health Corp. has priced its initial public offering at $24 per share.
In its final prospectus, the company says it will issue 54,166,670 shares in the offering that is expected to see gross proceeds total $1.3 billion. That’s more than an earlier plan by the company to sell $1 billion in shares.
Apotex says the offering includes a treasury offering of 35,416,666 shares for gross proceeds of $850 million and a secondary offering by certain shareholders of 18,750,004 shares for $450 million.
The selling shareholders have also granted the underwriters an over-allotment option for up to an additional 8,125,000 shares at the offer price.
The offering is expected to occur on or about June 16, subject to customary closing conditions. The shares traded for $27.05 in early afternoon trading on the Toronto Stock Exchange on an “if, as and when issued” basis Wednesday.
Apotex has a broad portfolio of generic drugs and consumer health products.
This report by The Canadian Press was first published June 10, 2026.
Companies in this story: (TSX:APTX)
Advertisement Advertise With Us